Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies
- Author
- CORRADINI, Paolo; TARELLA, Corrado; CICERI, Fabio; BENEDETTI, Fabio; RAMBALDI, Alessandro; SAJEVA, Maria R; TRESOLDI, Moreno; PILERI, Alessandro; BORDIGNON, Claudio; BREGNI, Marco; OLIVIERI, Attilio; GIANNI, Alessandro M; VOENA, Claudia; ZALLIO, Francesco; LADETTO, Marco; FALDA, Michele; LUCESOLE, Moira; DODERO, Anna
Department of Hematology, Istituto Scientifico HS Raffaele, Milano, Italy
Department of Hematology, Ospedali Riuniti, Bergamo, Italy
Department of Hematology, S Camillo Hospital, Rome, Italy
Department of Hematology, University of Torino, Italy
Department of Hematology, University of Verona, Italy
Division of Hematology, University of Ancona, Italy
Medical Oncology/BMT Unit, Istituto Nazionale Tumori, University of Milano, Italy - Source
Blood. 2002, Vol 99, Num 1, pp 75-82 ; ref : 34 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- The Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Association médicamenteuse Aziridine dérivé Cellule hématopoïétique Cellule souche Conditionnement Cyclophosphamide Fludarabine Homme Homogreffe Hémopathie maligne Maladie greffon hôte Moutarde à l'azote Oxazaphosphinane dérivé Protocole thérapeutique Purine nucléotide Rémission Thiophosphoramidate organique Thiotépa Traitement Traitement non myéloablatif Greffe
- Keyword (en)
- Antineoplastic agent Drug combination Aziridine derivatives Hematopoietic cell Stem cell Conditioning Cyclophosphamide Fludarabine Human Homograft Malignant hemopathy Graft versus host reaction Nitrogen mustard Oxazaphosphinane derivatives Therapeutic protocol Purine nucleotide Remission Organic thioamidophosphate Thiotepa Treatment Non myeloablative treatment Graft
- Keyword (es)
- Anticanceroso Asociación medicamentosa Célula hematopoyética Célula primitiva Acondicionamiento Ciclofosfamida Fludarabina Hombre Homoinjerto Hemopatía maligna Enfermedad injerto huesped Mostaza al nitrógeno Oxazafosfinano derivado Protocolo terapéutico Purina nucleótido Remisión Tiofosforamidato orgánico Tiotepa Tratamiento Injerto
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13421535
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1182/blood.V99.1.75 
https://dx.doi.org/10.1182/blood.V99.1.75
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1182\/blood.V99.1.75\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"82\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CORRADINI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Paolo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"TARELLA, Corrado\";i:1;s:13:\"CICERI, Fabio\";i:2;s:16:\"BENEDETTI, Fabio\";i:3;s:20:\"RAMBALDI, Alessandro\";i:4;s:15:\"SAJEVA, Maria R\";i:5;s:16:\"TRESOLDI, Moreno\";i:6;s:18:\"PILERI, Alessandro\";i:7;s:18:\"BORDIGNON, Claudio\";i:8;s:13:\"BREGNI, Marco\";i:9;s:17:\"OLIVIERI, Attilio\";i:10;s:20:\"GIANNI, Alessandro M\";i:11;s:14:\"VOENA, Claudia\";i:12;s:17:\"ZALLIO, Francesco\";i:13;s:14:\"LADETTO, Marco\";i:14;s:14:\"FALDA, Michele\";i:15;s:15:\"LUCESOLE, Moira\";i:16;s:12:\"DODERO, Anna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1182\/blood.V99.1.75\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"82\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CORRADINI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Paolo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"TARELLA, Corrado\";i:1;s:13:\"CICERI, Fabio\";i:2;s:16:\"BENEDETTI, Fabio\";i:3;s:20:\"RAMBALDI, Alessandro\";i:4;s:15:\"SAJEVA, Maria R\";i:5;s:16:\"TRESOLDI, Moreno\";i:6;s:18:\"PILERI, Alessandro\";i:7;s:18:\"BORDIGNON, Claudio\";i:8;s:13:\"BREGNI, Marco\";i:9;s:17:\"OLIVIERI, Attilio\";i:10;s:20:\"GIANNI, Alessandro M\";i:11;s:14:\"VOENA, Claudia\";i:12;s:17:\"ZALLIO, Francesco\";i:13;s:14:\"LADETTO, Marco\";i:14;s:14:\"FALDA, Michele\";i:15;s:15:\"LUCESOLE, Moira\";i:16;s:12:\"DODERO, Anna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1182\/blood.V99.1.75\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1182\/blood.V99.1.75\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"82\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CORRADINI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Paolo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"TARELLA, Corrado\";i:1;s:13:\"CICERI, Fabio\";i:2;s:16:\"BENEDETTI, Fabio\";i:3;s:20:\"RAMBALDI, Alessandro\";i:4;s:15:\"SAJEVA, Maria R\";i:5;s:16:\"TRESOLDI, Moreno\";i:6;s:18:\"PILERI, Alessandro\";i:7;s:18:\"BORDIGNON, Claudio\";i:8;s:13:\"BREGNI, Marco\";i:9;s:17:\"OLIVIERI, Attilio\";i:10;s:20:\"GIANNI, Alessandro M\";i:11;s:14:\"VOENA, Claudia\";i:12;s:17:\"ZALLIO, Francesco\";i:13;s:14:\"LADETTO, Marco\";i:14;s:14:\"FALDA, Michele\";i:15;s:15:\"LUCESOLE, Moira\";i:16;s:12:\"DODERO, Anna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1182\/blood.V99.1.75\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"82\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CORRADINI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Paolo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"TARELLA, Corrado\";i:1;s:13:\"CICERI, Fabio\";i:2;s:16:\"BENEDETTI, Fabio\";i:3;s:20:\"RAMBALDI, Alessandro\";i:4;s:15:\"SAJEVA, Maria R\";i:5;s:16:\"TRESOLDI, Moreno\";i:6;s:18:\"PILERI, Alessandro\";i:7;s:18:\"BORDIGNON, Claudio\";i:8;s:13:\"BREGNI, Marco\";i:9;s:17:\"OLIVIERI, Attilio\";i:10;s:20:\"GIANNI, Alessandro M\";i:11;s:14:\"VOENA, Claudia\";i:12;s:17:\"ZALLIO, Francesco\";i:13;s:14:\"LADETTO, Marco\";i:14;s:14:\"FALDA, Michele\";i:15;s:15:\"LUCESOLE, Moira\";i:16;s:12:\"DODERO, Anna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1182\/blood.V99.1.75\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"75\";s:8:\"\u0000*\u0000epage\";s:2:\"82\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CORRADINI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Paolo\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"TARELLA, Corrado\";i:1;s:13:\"CICERI, Fabio\";i:2;s:16:\"BENEDETTI, Fabio\";i:3;s:20:\"RAMBALDI, Alessandro\";i:4;s:15:\"SAJEVA, Maria R\";i:5;s:16:\"TRESOLDI, Moreno\";i:6;s:18:\"PILERI, Alessandro\";i:7;s:18:\"BORDIGNON, Claudio\";i:8;s:13:\"BREGNI, Marco\";i:9;s:17:\"OLIVIERI, Attilio\";i:10;s:20:\"GIANNI, Alessandro M\";i:11;s:14:\"VOENA, Claudia\";i:12;s:17:\"ZALLIO, Francesco\";i:13;s:14:\"LADETTO, Marco\";i:14;s:14:\"FALDA, Michele\";i:15;s:15:\"LUCESOLE, Moira\";i:16;s:12:\"DODERO, Anna\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:176:\"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
